Literature DB >> 31972332

The impact of size and surface ligand of gold nanorods on liver cancer accumulation and photothermal therapy in the second near-infrared window.

Huang Yang1, Hongpeng He2, Zongrui Tong1, Haibing Xia3, Zhengwei Mao4, Changyou Gao1.   

Abstract

Gold nanorods (GNRs) with longitudinal surface plasmon resonance (LSPR) peaks in second near-infrared (NIR-II) window have attracted a great amount of attention as photothermal transducer because of their inherently excellent photothermal transition efficiency, high biocompatibility and versatile surface functionalization. One key question for the application of these GNRs against tumors in vivo is which size/shape and surface ligand conjugation are promising for circulation and tumor targeting. In this study, we prepared a series of gold nanorods (GNRs) of similar aspect ratio and LSPR peaks, and thus similar photothermal transfer efficiency under irradiation of 980 nm laser, but with tunable size in width and length. The obtained GNRs were subjected to surface modification with PEG and tumor targeting ligand lactoferrin. With these tailor-designed GNRs in hand, we have the chance to study the impact of dimension and surface property of the GNRs on their internalization via tumor cells, photothermal cytotoxicity in vitro, blood circulation and tissue distribution pattern in vivo. As a result, the GNRs with medium size (70 nm in length and 11.5 nm in width) and surface PEG/LF modification (GNR70@PEG-LF) exhibit the fastest cell internalization via HepG2 cells and best photothermal outcome in vitro. The GNR70@PEG-LF also display long circulation time and the highest tumor accumulation in vivo, due to the synergetic effect of surface coating and dimension. Finally, tumor ablation ability of the GNRs under irradiation of 980 nm light were validated on mice xenograft model, suggesting their potential photothermal therapy against cancer in NIR-II window.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gold nanorods; Lactoferrin; Photothermal therapy; Size; Tumor targeting

Year:  2020        PMID: 31972332     DOI: 10.1016/j.jcis.2020.01.026

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  7 in total

Review 1.  Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives.

Authors:  Madhusudhan Alle; Garima Sharma; Seung-Hwan Lee; Jin-Chul Kim
Journal:  J Nanobiotechnology       Date:  2022-07-02       Impact factor: 9.429

Review 2.  Gold Nanorod-Assisted Photothermal Therapy and Improvement Strategies.

Authors:  Mitchell Lee Taylor; Raymond Edward Wilson; Kristopher Daniel Amrhein; Xiaohua Huang
Journal:  Bioengineering (Basel)       Date:  2022-05-05

3.  The Pimpled Gold Nanosphere: A Superior Candidate for Plasmonic Photothermal Therapy.

Authors:  Behzad Nasseri; Mustafa Turk; Kemal Kosemehmetoglu; Murat Kaya; Erhan Piskin; Navid Rabiee; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2020-04-24

Review 4.  Recent Advances in Transition-Metal Based Nanomaterials for Noninvasive Oncology Thermal Ablation and Imaging Diagnosis.

Authors:  Qiuxia Peng; Zhangbo Qian; Huali Gao; Kun Zhang
Journal:  Front Chem       Date:  2022-04-14       Impact factor: 5.545

5.  Thermal and Medium Stability Study of Polyvidone-Modified Graphene Oxide-Coated Gold Nanorods with High Photothermal Efficiency.

Authors:  Thabang Calvin Lebepe; Oluwatobi Samuel Oluwafemi
Journal:  Nanomaterials (Basel)       Date:  2022-09-27       Impact factor: 5.719

Review 6.  Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view.

Authors:  Xingyue Huang; Yang Lu; Mingxue Guo; Shouying Du; Ning Han
Journal:  Theranostics       Date:  2021-06-04       Impact factor: 11.556

7.  Graphene Oxide-Gold Nanorods Nanocomposite-Porphyrin Conjugate as Promising Tool for Cancer Phototherapy Performance.

Authors:  Thabang Calvin Lebepe; Sundararajan Parani; Vuyelwa Ncapayi; Rodney Maluleke; Grace It Mwad Mbaz; Olufunto Tolulope Fanoro; Jose Rajendran Varghese; Atsuki Komiya; Tetsuya Kodama; Oluwatobi Samuel Oluwafemi
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.